CareDx, Inc. Fair Value Disclosure
| December 31, 2025 | |||||||||||||||||||||||
| Fair Value Measured Using | |||||||||||||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Total Balance | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Cash equivalents: | |||||||||||||||||||||||
| Money market funds | $ | 21,435 | $ | — | $ | — | $ | 21,435 | |||||||||||||||
| Total | $ | 21,435 | $ | — | $ | — | $ | 21,435 | |||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Short-term liabilities: | |||||||||||||||||||||||
| Contingent consideration | $ | — | $ | — | $ | 1,617 | $ | 1,617 | |||||||||||||||
| Long-term liabilities: | |||||||||||||||||||||||
| Contingent consideration | — | — | 161 | 161 | |||||||||||||||||||
| Total | $ | — | $ | — | $ | 1,778 | $ | 1,778 | |||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||
| Fair Value Measured Using | |||||||||||||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Total Balance | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Cash equivalents: | |||||||||||||||||||||||
| Money market funds | $ | 52,230 | $ | — | $ | — | $ | 52,230 | |||||||||||||||
| Total | $ | 52,230 | $ | — | $ | — | $ | 52,230 | |||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Short-term liabilities: | |||||||||||||||||||||||
| Contingent consideration | $ | — | $ | — | $ | 2,414 | $ | 2,414 | |||||||||||||||
| Long-term liabilities: | |||||||||||||||||||||||
| Contingent consideration | — | — | 174 | 174 | |||||||||||||||||||
| Total | $ | — | $ | — | $ | 2,588 | $ | 2,588 | |||||||||||||||
| (Level 3) | ||||||||
Contingent Consideration | ||||||||
Balance at December 31, 2023 | $ | 7,930 | ||||||
Change in estimated fair value of contingent consideration from business combination | 931 | |||||||
Change in estimated fair value of contingent consideration from asset acquisition | (448) | |||||||
Deduction from contingent consideration | (500) | |||||||
| Payment related to contingent consideration | (5,325) | |||||||
Balance at December 31, 2024 | 2,588 | |||||||
Change in estimated fair value of contingent consideration from business combination | 704 | |||||||
Change in estimated fair value of contingent consideration from asset acquisition | (14) | |||||||
| Payment related to contingent consideration | (1,500) | |||||||
Balance at December 31, 2025 | $ | 1,778 | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Feb 24, 2022 | |
| 2020 | Feb 24, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Mar 6, 2019 | |
| 2017 | Mar 22, 2018 | |
| 2016 | Apr 21, 2017 | |
| 2015 | Mar 29, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.